Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

890
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
890
Classification of Skeletal Muscle Fibers01:48

Classification of Skeletal Muscle Fibers

56.5K
Skeletal muscles continuously produce ATP to provide the energy that enables muscle contractions. Skeletal muscle fibers can be categorized into three types based on differences in their contraction speed and how they produce ATP, as well as physical differences related to these factors. Most human muscles contain all three muscle fiber types, albeit in varying proportions.
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
56.5K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

966
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
966
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk-based environmental assessment of the use of ten products from bottom ash treatment plants based on leaching and ecotoxicological tests.

Waste management (New York, N.Y.)·2026
Same author

Stroke-related ipsilateral haemiparesis: a single-centre case series and literature review.

European stroke journal·2026
Same author

Modifying disease registries to address the evolving field in rare diseases: the iSMAc/ITASMAc experience in spinal muscular atrophy.

Frontiers in neurology·2026
Same author

Chronic Inflammatory Demyelinating Polyradiculoneuropathy-Like Neuropathy in Heterozygous <i>C9orf72</i> Mutation: A Case Report.

Case reports in neurology·2026
Same author

Introduction of robotics into a well-established navigation OR team for TKA does not increase surgical time. A one center evaluation.

Journal of robotic surgery·2026
Same author

Description and validation of a portable system for biomechanical ex vivo knee kinematics and laxity assessment in simulated intra-operative scenarios.

Journal of experimental orthopaedics·2026

Related Experiment Video

Updated: Jul 10, 2025

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

19.6K

Diagnostics in skeletal muscle channelopathies.

Alex Vicino1,2, Raffaella Brugnoni1, Lorenzo Maggi1

  • 1Neurology IV Unit, Neuroimmunology and Neuromuscular Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Expert Review of Molecular Diagnostics
|November 27, 2023
PubMed
Summary

Skeletal muscle channelopathies (SMCs) involve genetic mutations affecting muscle excitability, causing myotonia or episodic weakness. Diagnosis requires a structured approach including clinical data, neurophysiology, and genetic testing for accurate genotype-phenotype correlation.

Keywords:
CLCN1KCNJ2KCNJ5Non-dystrophic myotonia; periodic paralysisRYR1 genesSCN4A

More Related Videos

Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

8.9K
Tissue Triage and Freezing for Models of Skeletal Muscle Disease
05:58

Tissue Triage and Freezing for Models of Skeletal Muscle Disease

Published on: July 15, 2014

40.3K

Related Experiment Videos

Last Updated: Jul 10, 2025

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

19.6K
Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

8.9K
Tissue Triage and Freezing for Models of Skeletal Muscle Disease
05:58

Tissue Triage and Freezing for Models of Skeletal Muscle Disease

Published on: July 15, 2014

40.3K

Area of Science:

  • Neurology
  • Genetics
  • Molecular Biology

Background:

  • Skeletal muscle channelopathies (SMCs) are a diverse group of disorders arising from mutations in skeletal ion channels.
  • These mutations disrupt normal muscle excitability, leading to conditions like non-dystrophic myotonias (NDMs) or periodic paralyses (PPs).

Purpose of the Study:

  • To outline a structured diagnostic approach for suspected skeletal muscle channelopathies.
  • To emphasize the importance of integrating clinical, neurophysiological, and genetic data for accurate diagnosis.

Main Methods:

  • Detailed personal and family history, clinical examination.
  • Neurophysiological tests to confirm myotonia and exclude other diagnoses.
  • Electrodiagnostic studies, Sanger sequencing, next-generation sequencing panels, exome-variant, or whole-genome sequencing for genetic confirmation.

Main Results:

  • Diagnosis relies heavily on clinical data, with neurophysiology aiding in phenotype definition.
  • Genetic testing is crucial for definitive diagnosis, with advanced techniques available for complex cases.
  • Challenges remain in establishing precise genotype-phenotype correlations and characterizing unsolved cases.

Conclusions:

  • A systematic diagnostic pathway combining clinical evaluation with advanced genetic analysis is essential for diagnosing SMCs.
  • Further research is needed to improve genotype-phenotype correlations and identify genetic causes in undiagnosed patients.